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Effects of Smoking on Interdigestive 
Gastrointestinal Motility 
W. MICHAEL McDONNELL, MD and CHUNG OWYANG, MD 
The effect of smoking on interdigestive gastrointestinal motility is little studied but may play 
a role in gastrointestinal morbidity. We studied gastroduodenal motility in 10 volunteers (five 
smokers and five nonsmokers) using a water-perfused pressure catheter. A pH probe was 
placed in the duodenal bulb. Baseline motility was recorded until phase III of the migrating 
motor complex had occurred in the stomach three times in order to record two complete 
cycles of MMC activity. Subjects then began smoking until phase III activity occurred again 
(mean duration of smoking 117 min). During the control period, all subjects had normal 
MMC cycles and there were no differences between smokers and nonsmokers. While 
smoking, no gastric phase III was observed in any subject and gastric motility was markcdly 
reduced. In seven of 10 subjects, smoking did not prevent the occurrence of normal duodenal 
phase III activity. Three subjects had no duodenal phase III activity during smoking. The 
duodenal pH profile did not change during smoking and motilin levels continued to fluctuate 
in conjunction with phase III activity. In conclusion, smoking abolished phase III activity in 
the stomach without affecting the plasma motilin cyclic fluctuations or duodenal bulb pH. In 
contrast, smoking has little effect on duodenal motility. 
KEY WORDS: intcrdigcstive migrating motor complex; motilin; duodenal pH: gastric motility; smoking: tobacco: 
nicotine. 
Gastrointestinal complications associated with smok- 
ing are well described and include increased inci- 
dence of peptic ulcer disease, increased rate of recur- 
rence of peptic ulcers, decreased response to 
treatment of ulcers with H2-receptor blockers, and 
increased incidence of serious complications from 
peptic ulcer disease (1-5). The reasons for increased 
gastrointestinal morbidity from smoking are unclear. 
Numerous studies investigating acid output, gastric 
blood flow, prostaglandin production, duodenal pH, 
and other parameters have been inconclusive (6, 7). 
Recently increased duodenogastric reflux secondary 
to gastric hypomotility has been proposed to play a 
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role in the pathogenesis of gastric ulcer (8, 9). It is 
conceivable that smoking may inhibit gastric motility, 
which in turn promotes duodenogastric reflux and/or 
delays gastric emptying of acid. However, the effects 
of smoking on fasting gastrointestinal motility are 
little studied. 
Fasting motility is characterized by the interdiges- 
rive migrating motor complex (MMC). The MMC 
cycles during the fasting state and culminates in a 
wave of intense phasic contractions htsting about 5 
min (phase II1) which begin in the antrum and pro- 
ceed through the small intestine. This is followed by a 
period of quiescence with little or no contractile ac- 
tivity (phase I) lasting about 15-60 min and then by a 
period of intermittent and irregular contractions 
(phase II) lasting another 15-60 min. Phase II leads 
into another phase III contractile wave and the cycle 
is completed. Phase III of the MMC has been re- 
ferred to as the "housekeeper" of the gastrointestinal 
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SMOKING INHIBITS INTERDIGESTIVE GASTRIC MOTILITY 
tract ,  as these  powerful  con t rac t ions  not  only play an 
impor t an t  role in gastr ic  empty ing  of  indigest ible  
solids but  also enhance  gastr ic  empty ing  of  secre t ions  
inc lud ing  gas t r ic  acid  (10). W e  hypo thes i ze  tha t  
smoking  inhibits  in terdiges t ive  M M C  activity and in- 
duces  a hypomot i l i ty  state.  To test this hypothesis ,  we 
p e r f o r m e d  s tudies  on volunteers ,  bo th  smokers  and 
nonsmokers ,  dur ing  cont ro l  and smoking  per iods  in 
the fasting s tate  to d e t e r m i n e  the acute  effects o f  
smoking  on g a s t r o d u o d e n a l  mot i l i ty  and duodena l  
pH.  
M A T E R I A L S  AND M E T H O D S  
Subjects. Ten volunteers, five smokers and five nonsmok- 
ers, between the ages of 18 and 33 years (mean 25.8 years -+ 
1.5 SEM) were recruited. There were four women and six 
men, and all were in excellent health. These studies were 
approved by the University of Michigan Institutional Re- 
view Board and informed consent was obtained from all 
subjects. 
Equipment. Gastrointestinal motor activity was mea- 
sured by a sensitive water perfusion system consisting of a 
pneumohydraulic capillary infusion pump that perfuses a 
polyvinyl catheter at 0.25 ml/min (Arndorfer Medical Spec., 
Inc., Racine, Wisconsin). The catheter had eight circumfer- 
ential lumens with two duodenal ports 6 and 18 cm from the 
end and six gastric ports 30-35 cm from the end. The 
catheter was connected through external transducers (mod- 
el P23XL, Gould Inc, Oxnard, California) to a Gould pen 
recorder (Instruments Div., Gould Inc., Cleveland, Ohio). 
A pH probe was attached to the perfusion catheter 3 cm 
distal to the last gastric pressure port for eventual place- 
ment in the duodenal bulb. The 150-cm pH probe was 
connected to a pH meter (Radiometer Copenhagen PHM 
G2) and a continuous reading was recorded on the Gould 
pen recorder (Figure 1). 
Study Design. After an overnight fast gastrointestinal 
intubation was performed under fluoroscopic control. The 
two distal ports were located in the mid-duodenum and 
near the ligament of Treitz. The proximal six ports were 
spread across the antrum, and the pH probe was placed in 
the duodenal bulb (Figure 1). Subjects were then brought to 
the Clinical Research Center at the University of Michigan 
and placed in a bed with the head elevated 30-45 ~ for 
observation. A heparin lock was placed using a 20-gauge 
butterfly needle for obtaining peripheral blood samples. 
Smokers did not smoke for 18 hr before the study period. 
Subjects were then observed for the first phase I l l  of the 
MMC in the gastric antrum. Phase II1 is identified by an 
intense burst of regular rhythmic contractions at a rate 
corresponding to the underlying slow-wave activity of the 
gut (3 contractions per minute in the antrum and 11-12 
contractions per minute in the duodenum) lasting 3-10 min 
(Figure 2). This is followed by a period of quiescence, which 
is the hallmark phase I of the MMC. The first MMC phase 
Ill  was considered the beginning of the study period. Sub- 
jects were then observed through two more phase III 
MMCs, thus having recorded two complete control MMC 






Fig l. Gastroduodenal motility tube with pH probe attached distal 
to the last gastric port in the stomach and small intestine. 
began smoking. Smokers smoked a standard 1.2-mg nico- 
tine cigarette (Phillip Morris, Richmond, Virginia) contin- 
uously for this portion of the study. They were instructed to 
smoke at their usual rate. Nonsmokers smoked a standard 
cigar (Consolidated Cigar Co., Ft. Lauderdale, Florida) 
continuously. They were instructed to smoke slowly and 
simply draw smoke into their mouth and blow it out. This 
continued until the next MMC phase III and then the study 
was terminated or, if a phase III MMC did not occur at the 
expected time, the study was continued as long as the 
subject was able to tolerate the experiment. Cigars were 
used for nonsmokers because a nonsmoker without smok- 
ing tolerance could not be expected to inhale a cigarette. 
Cigarette tobacco is flu cured and acidic. The nicotine is 
ionized and therefore not well absorbed by buccal mucosa 
(l  1). Cigar tobacco is air cured and alkaline. The nicotine is 
ionized and readily absorbed by the buccal mucosa (11). 
Therefore, in a nonsmoker, a comparable smoking effect 
can be achieved by using a cigar rather than a cigarette. 
Blood was drawn every 15 min throughout the study period. 
Motilin. Plasma was immediately separated and stored at 
-70~ until time of assay. Plasma motilin was measured 
with a radioimmunoassay by the Michigan Diabetes Re- 
search Unit as previously described (12). 
Motility Measurements. Although the polyvinyl catheter 
we used had six lumens in the stomach, we used only the 
four most distal ports since we were interested in antral 
activity. In interpreting results, we picked a single antral 
tracing because all antral tracings provided similar informa- 
tion. Motility was initially assessed qualitatively for the 
presence of phase I, phase II, and phase III activity. The 
time of each cycle was measured in minutes from the 
beginning of phase III activity to the beginning of the next 
phase III. The motility index (MI) was determined by 
measuring the area under the curve on the paper tracing 
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using a personal computer (IBM, Armonk, New York) and 
digitizer board (Sumnlagraphics, Fairfield, Connecticut). 
Gastric MI represents the motor activity observed for the 
entire MMC cycle and does not distinguish between gastric 
phase II and phase III activity. Gastric motility data are 
expressed as Ml/min x 100. The duodenal MI represents 
only the activity seen during phase III of the MMC. 
Duodenal pH. Duodenal pH was monitored during the 
entire study period to determine if the duodenal bulb was 
more acidic during the smoking period. Accurate position 
of the pH probe was ensured by securing the probe 3 cm 
beyond the last gastric pressure port. If the pH probe 
migrated distally, the last gastric port readings would iden- 
tify its location in the pylorus or duodenum, and if the pH 
probe migrated proximally, the pH would drop to a contin- 
uous pH 1-2 reading. 
Statistical Methods. Data were averaged and expressed 
as - SEM. Control and smoking period data were compared 
using the paired and unpaired t test. [Only one intervention 
was performed (smoking) so analysis of variance was not 
required]. Since multiple measurements were made in this 
study, the issue of simultaneous inference was addressed 
using the Bonferroni correction approach (13). One vari- 
able measured may be dependent on another measured 
variable: therefore, the significance of that variable would 
depend on the significance of the other variable. The Bon- 
ferroni method states that to reach a significance of P = 
(I.05, the individual variable measured must be significant at 
0.05 divided by the number of variables measured. Five 
variables were measured in this study (gastric motility, 
duodenal motilit),, cycle length, duodenal pH, and serum 
motilin), which means a P value of (I.()l would be required 
to reach statistical significance. 
RESULTS 
Motor  Activity. All subjects had normal interdiges- 
tive MMC activity (normal phase I, II and III wave 
morphology and periodicity) during the control pe- 
riod. In the control period each subject was followed 
through two interdigestive MMC cycles (with one 
exception) by observing three phase III contraction 
waves, All phase III contractions began in the stom- 
ach with normal aboral progression to the duodenum. 
Smoking produced a dramatic drop in gastric motor  
activity throughout the cycle, and no subject had 
gastric phase Ill activity while smoking (Figure 2). 
Two subjects did not have a single gastric contraction 
while smoking (Figure 3). In seven subjects the end of 
the cycle was heralded by the abrupt onset of duode- 
nal phase II1 contractions (Figure 2). Three subjects 
werc observed for 130, 150, and 317 rain while smok- 
ing and did not demonstrate  any duodenal phase III 
activity. During the smoking period an average of 2.2 
_+ 0.2 cigars and 9.4 _+ 1.4 cigarettes were consumed. 
Each volunteer had a dramatic decrease in gastric 
motor  activity while smoking (Figure 3). There was no 
significant difference in gastric motility between 
smokers and nonsmokers; therefore the data pre- 
sented in Figure 4 combine both groups. The average 
gastric MI/m during the control period was 33.6 +_ 2.8 
cm 2 and while smoking it dropped to 4.2 _+ 1.4 cm 2 (P 
< 0.001) (Figure 4). The mean cycle time was 97.1 _+ 
6.4 min during the control period, which was not 
significantly different than the MMC cycle length in 
the seven volunteers who had a duodenal phase III 
while smoking (82 + 8.1 min). Duodenal motor  ac- 
tivity observed while smoking was not significantly 
different than during the control period (Figure 4). 
The mean duodenal phase III MI was 14.7 +_ 1.2 
during the first control period, 11.8 + 1.2 during the 
second control period, and 11.6 _+ 1.2 during the 
smoking period. 
Duodenal pH. Typical pH readings were seen dur- 
ing the control and smoking periods in all subjects, ie, 
the pH was very stable during phase I, always remain- 
ing between 7 and 8, and during phase II, the baseline 
becoming erratic with the pH dropping as low as 2 on 
occasion (see Figure 2). The occurrence of phase III 
was usually accompanied by stabilization of the duo- 
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Fig 3. Gastric motility index per minute (Ml/min x l(10) of vohm- 
teers for each control period and smoking period. Control period 1 
and 2 refer to the first and second interdigestive MMC cycle 
observed prior to the smoking period. The first five volunleers are 
nonsmoke rs. 
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Fig 4. Gastroduodenal motility during control [N = 19 sincc two 
complete MMCs were observed (except volunteer 10)] and smok- 
ing periods (N = 10). Gastric motility expressed as MI (ie, gastric 
MI per MMC cycle) or Ml/minute x 100 shows a marked decrease 
in motor activity during the smoking period (P < 0.001). Duodenal 
MI in the seven volunteers who had a duodenal MMC phase III 
were not different than duodenal MI in the control period. 
denal pH at around 7. These data were quantitated by 
determining the percentage of time the pH was lower 
than 4.0 during the cycle period and comparing con- 
trol cycles with smoking cycles, pH tracings were 
complete for four smokers and four nonsmokers. The 
pH was less than 4.0 an average of 13 + 6.4% of the 
cycle time during the control period and 9.2 _+ 2.1% 
of the time during the smoking period. There were no 
significant differences between these values, nor were 
there any statistical differences between smokers and 
nonsmokers during the control or smoking periods. 
Plasma Motilin. Motilin values were available for 
nine volunteers, including six of the seven volunteers 
whose study ended in a duodenal MMC phase III 
while smoking. All volunteers had normal peaks of 
motilin just prior to phase III activity and troughs 
during phase I (Figure 5). To quantitate these data, 
the trough during phase I was compared to the peak 
within 10 min of the following phase III (Figure 6). 
The average trough motilin value during phase I was 
165 +_ 20 pg/ml for the control period and 169 _+ 33 
pg/ml during the smoking period (Figure 6). The 
average peak motilin value just prior to phase III was 
275 __ 35 pg/ml during the control period (N = 11) 
and 261 _+ 42 pg/ml during the smoking period (N = 
6). The percentage increase in motilin from phase I to 
phase III ranged from 26 to 155% with a mean of 76 
__ 13% during the control period and a mean of 60 + 
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Fig 5. Serum motilin values for one volunteer throughout the study 
period. Note that motilin peaks around the time of each MMC 
phase III and troughs soon afterwards. 
11% during the smoking period. There was no differ- 
ence in the percentage increase in motilin between 
the control and smoking phase using either the paired 
(P = 0.40) or unpaired t test (P = 0.43). 
DISCUSSION 
The study design employed has the advantage of 
doing the control period and the smoking period on 
the same day during the same intubation. This elim- 
inates variables that could arise by doing the test on 
different days and affect motility patterns, such as 
trauma during intubation, emotional state at the time 
of the test, mild viral illness, and other poorly under- 
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Fig 6. Serum motilin values for six of seven subjects who had a 
duodenal MMC phase III while smoking. Serum motilin values 
measured during MMC phase I are compared with peak motilin 
values measured within 10 min of MMC phase III. An increase in 
serum motilin from MMC phase ! to MMC III is seen for each 
cycle of each person (paired t; P < 0.001 for control cycle and P = 
0.001 for smoking cycle). 
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stood variables that effect motility. A potential prob- 
lem in our study design is that the smoking portion is 
always done after the control portion of the exam. In 
our experience, motility after tubal intubation is er- 
ratic but after a period of observation typical patterns 
return, and we have not observed that erratic motility 
patterns occur after long periods of intubation. While 
testing order could be a confounding factor in our 
results, it should be noted that the smoking cycle for 
each person is compared with two control cycles and 
the differences are marked. 
Our results demonstrate that in the interdigestive 
state smoking eliminates gastric MMC phase III ac- 
tivity and markedly suppresses gastric motor activity 
throughout the cycle. The effect on duodenal activity 
was not as straightforward. In seven subjects no dif- 
ferences in motility index or MMC cycle length were 
observed. However, three subjects who smoked for 
130, 150, and 317 min had no duodenal phase III 
activity while smoking. The study was stopped in each 
of these cases because the total time the subject had 
volunteered was greater than 7 hr and they were 
unwilling to participate further. It could be said that 
this period of observation was not long enough and 
observation for a longer time may have shown gastric 
or duodenal MMC activity. In any case, it appears 
that the inhibitory effect of smoking was much more 
pronounced on gastric than on duodenal phase III 
activity. Similarly, hyperglycemia has also been shown 
to inhibit gastric but not duodenal phase III activity 
(14). There is some experimental evidence to suggest 
that gastric and intestinal MMCs may be under sep- 
arate control. Poitras et al (15) demonstrated the 
existence of motilin-independent phase III activity in 
their canine experiments, and Chung and Diamant 
(16) reported vagal blockade abolished gastric but not 
duodenal phase III activity. Smoking did not change 
the duodenal pH or peaks in serum motilin concen- 
tration prior to phase III activity. 
There are no studies examining the effect of smok- 
ing on interdigestive motility using gastroduodenal 
manometric techniques. The effects of nicotine on 
gastrointestinal motility have been studied in dogs 
(12, 17). In the fed state intravenous nicotine inhib- 
ited gastric and duodenal activity in a dose-dependent 
fashion with nausea and vomiting sometimes noted at 
higher doses. Nicotine given during phase III interdi- 
gestive activity abolished motor activity and fre- 
quently merged the pattern into phase I. Nicotine had 
no stimulatory activity when given during the quies- 
cent phase I period. Epinephrine, norepinephrine, 
and ganglionic stimulants including DMPP (dimethyl- 
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phenylpiperazine) had a similar effect on gastroduo- 
denal motility as nicotine. Reserpine, which depletes 
catecholamines peripherally, could block the effects 
of both nicotine and epinephrine. This led investiga- 
tors to conclude that the inhibitory effects of nicotine 
in the whole animal are due to increased sympathetic 
tone mediated through the effects of nicotine on the 
sympathetic ganglia, adrenal medulla, and central 
nervous system rather than inhibitory effects on the 
parasympathetic system. 
Interdigestive gastrointestinal motility is a product 
of myogenic slow-wave activity regulated by neural 
and hormonal control mechanisms (18). Motilin is 
one factor that has a significant role in initiating 
MMC phase III activity. Motilin peaks just prior to 
the upper gastroduodenal phase III excitation wave. 
Exogenous motilin infusion can initiate an ectopic 
phase III contraction (19), and infusion of antimotilin 
antibodies will inhibit phase III activity in dogs (20). 
In our study, motilin peaks prior to all phase III 
activity in the control periods and while smoking prior 
to the appearance of a duodenal phase III. This 
suggests that the effect of smoking on motility is not 
mediated through inhibition of motilin release but 
more likely is mediated through the effect of nicotine 
on the central and autonomic nervous system as de- 
scribed above in dogs. 
Duodenal pH was studied because previous inves- 
tigators have described decreased duodenal pH while 
smoking and decreased pancreatic and biliary bicar- 
bonate secretion with tobacco or nicotine exposure, 
although these findings have been controversial (21- 
25). Furthermore, duodenal bulb pH has a regulatory 
effect on interdigestive gastrointestinal motility. Acid 
in the duodenal bulb will inhibit gastric phase III 
activity, presumably preventing further duodenal 
acidification (26, 27). If smoking did cause a decrease 
in duodenal bulb pH, this would be a possible cause 
of duodenal ulcer formation and would be a possible 
mechanism for changes in gastroduodenal motility. 
We did not see a significant drop in duodenal pH 
during the smoking period compared to the control 
period, indicating the inhibition of gastric motility 
during smoking was not due to duodenal acidification. 
In summary, smoking caused a profound diminu- 
tion of gastric activity and elimination of all gastric 
phase III activity in smokers and nonsmokers while 
smoking but had no effect on duodenal activity in 
most subjects. Neither duodenal pH nor serum moti- 
lin seem to mediate this effect. These changes are 
similar to changes in motility seen by infusion of 
nicotine into dogs and therefore may be mediated 
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through increased sympathetic tone. There was no 
difference in motility between smokers and nonsmok- 
ers during the control period. Future studies should 
be directed at the role of nicotine in gastrointestinal 
motility and whether modulators of sympathetic tone 
can alter these effects. 
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